Start of Main Content

Genetic and Rare Diseases (GARD) 

What is the Genetic and Rare Diseases (GARD) information center?

GARD is a program by the National Center for Advancing Translational Sciences (NCATS) also funded by the National Human Genome Research Institute (NHGRI). It is responsible for providing the public access to reliable, current, and easy-to-understand information about rare or genetic diseases. The information within GARD is available in both English and Spanish.  

In addition to data about rare diseases, GARD includes actionable information that can help someone manage their care or find a diagnosis.   

Why is GARD important for healthcare? 

GARD aims to help those with rare diseases, or those close to individuals with rare diseases, meet common challenges such as getting a diagnosis, accessing information, and finding resources. With GARD, patients can be sure that they are looking at the most accurate and up-to-date information, provided in a format that is easy to understand.  

With increased knowledge, those with rare diseases can feel more secure in their condition and the available treatments. They can also feel confident that they are receiving the best possible care for their rare disease or have more courage to speak up to their doctor with a suggestion.  

GARD also offers ways for patients to connect with other patients and families to have a community of support and learn about care centers, the latest treatments, and opportunities for research trials.